Xyla acknowledges the mounting pressure faced by the mental health system amidst a surge in demand for neurodevelopment assessments, we understand the challenges posed by growing wait lists and the strain on welfare.

Our specialised service aims to be your partner in addressing these challenges by offering support in managing wait lists and optimising resource utilisation. We collaborate closely with your teams to efficiently tackle the backlog of assessments, providing the flexibility for you to maintain control over the end-to-end case flow and retain decision-making authority in the diagnostic process.

Through a collaborative and co-designed approach, we ensure that our service seamlessly integrates with your existing face-to-face services, creating a complimentary pathway that enhances overall efficiency while prioritising the well-being of those awaiting neurodevelopment assessments. 

Why Xyla?

Flexible delivery options

Face to face, remote, or hybrid neurodevelopment assessments services.

Gold standard excellence

Our assessments adhere to NICE guidance mirroring established pathways within the NHS for unparalleled quality assurance.

Tailored support

Free advisory services to design bespoke solutions, perfectly aligned with your evolving needs and demands.

UK’s largest staffing provider

Access to our workforce of over 2500 experienced clinicians and expert administrators.

Contact us

To learn more about our mental health assessments and how they could benefit your organisation, get in touch with our team today.   

Xyla is a trading name of ICS Operations Ltd (Registered No 4793945), Pulse Healthcare Limited (Registered No 3156103), Carehome Selection Limited (Registered No 3091598), Independent Clinical Services Limited (Registered No 4768329) and CHS Healthcare Software Limited (Registered No 11582111)